Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Summer Research Program for Diversity Students in PharmacoNeuroImmunology
Molitor, T. W. (PI), Carroll, D. M. (CoI), Gewirtz, J. C. (CoI), Hatsukami, D. K. (CoI) & Pravetoni, M. (CoI)
7/1/21 → 5/31/26
Project: Research project
-
Adjuvanted Opioid Vaccine for Treating Fentanyl Use Disorder
Raleigh, M. D. (PI), Borgatti, A. M. (CoI) & Pravetoni, M. (Prior Principal Investigator)
UNIVERSITY OF MONTANA, NIH Nat'l Inst of Allergy & Infect Dis
9/30/20 → 9/29/25
Project: Research project
-
A Fentanyl Vaccine to Prevent Overdose
Pravetoni, M. (PI)
HEPIONE THERAPEUTICS, INC, NATIONAL INSTITUTES OF HEALTH (NIH)
9/30/20 → 3/31/22
Project: Research project
-
Antibody-based countermeasures against fentanyl and its analogues
Pravetoni, M. (PI)
9/1/20 → 12/31/21
Project: Research project
-
Phase 1a/1b Clinical Trials of Multivalent Opioid Vaccine Components
Raleigh, M. D. (PI) & Pravetoni, M. (Prior Principal Investigator)
RESEARCH FOUNDATION FOR MENTAL HYGIENE, NATIONAL INSTITUTES OF HEALTH (NIH)
9/1/19 → 3/31/23
Project: Research project
-
A humanized monoclonal antibody attenuates fentanyl self-administration and reverses and prevents fentanyl-induced ventilatory depression in rhesus monkeys
Galbo-Thomma, L. K., Marecki, C., Kim, C. M., Hiranita, T., Taylor, J. R., Maguire, D. R., Hicks, D. M., Gebo, A., Khaimraj, A. J., Baehr, C., Pravetoni, M. & France, C. P., 2025, (Accepted/In press) In: Psychopharmacology.Research output: Contribution to journal › Article › peer-review
-
CD4+ but not CD8+ T cells are required for protection against severe guinea pig cytomegalovirus infections
Rollman, T. B., Berkebile, Z. W., Hicks, D. M., Hatfield, J. S., Chauhan, P., Pravetoni, M., Schleiss, M. R., Milligan, G. N., Morgan, T. K. & Bierle, C. J., Nov 2024, In: PLoS pathogens. 20, 11, e1012515.Research output: Contribution to journal › Article › peer-review
Open Access -
Evaluating the rate of reversal of fentanyl-induced respiratory depression using a novel long-acting naloxone nanoparticle, cNLX-NP
Averick, S. E., Kassick, A. J., Song, D., Zhang, B., Vigliaturo, J., Luengas, D., Silva-Ortiz, P., Pravetoni, M. & Raleigh, M. D., 2024, In: Frontiers in Psychiatry. 15, 1366186.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Identification and biophysical characterization of a novel domain-swapped camelid antibody specific for fentanyl
Gallant, J. P., Hicks, D., Shi, K., Moeller, N. H., Hoppe, B., Lake, E. W., Baehr, C., Pravetoni, M., Aihara, H. & LeBeau, A. M., Aug 2024, In: Journal of Biological Chemistry. 300, 8, 107502.Research output: Contribution to journal › Article › peer-review
Open Access -
Monoclonal Antibodies Engineered with Fc Region Mutations to Extend Protection against Fentanyl Toxicity
Khaimraj, A., Baehr, C. A., Hicks, D., Raleigh, M. D. & Pravetoni, M., Sep 1 2024, In: Journal of Immunology. 213, 5, p. 663-668 6 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations
Press/Media
-
U of M researchers receive $2.4 million grant to develop fentanyl vaccines and antibodies
10/7/20
1 item of Media coverage
Press/Media: Research